Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table

—– Akili Adds Amgen Ven­tures and M Ven­tures* to Series B Financ­ing, Increas­ing Round to $42.4 Mil­lion (press release): “Akili Inter­ac­tive Labs, Inc. (“Akili”), a dig­i­tal med­i­cine com­pa­ny devel­op­ing nov­el, non-phar­­ma­­co­log­i­­cal ther­a­peu­tics and diag­nos­tics for cog­ni­tive dis­or­ders, today announced an $11.9 mil­lion expan­sion of its recent Series B financing. 

Read More

Dr. Michael Merzenich: To harness Neuroplasticity for cognitive enhancement, we need to think “Fitness” more than “Games”

(Edi­tor’s Note: In order to help read­ers famil­iar­ize them­selves with the work and think­ing of Dr. Michael Merzenich, one of the win­ners of the 2016 Kavli Prize in Neu­ro­science for ground­break­ing work on neu­ro­plas­tic­i­ty, we are con­dens­ing and repub­lish­ing the com­pre­hen­sive con­ver­sa­tion that Dr. Merzenich and Alvaro Fer­nan­dez had in 2009, in prepa­ra­tion for the inaugural…

Read More

Challenge: How to spur meaningful, targeted & safe adoption of emerging neurotechnologies

A cap that treats depres­sion? Check the sci­ence before get­ting excit­ed (The Guardian): “Yes­ter­day, an arti­cle in the Entre­pre­neurs sec­tion of the Guardian pur­port­ed to reveal a “cloth cap that could help treat depres­sion”. This claim has caused some alarm in the neu­ro­science and men­tal health fields, so it’s impor­tant to look a lit­tle more…

Read More

Report: Revolutions in neurotechnology will soon influence every aspect of human life

Cen­ter for Neu­rotech­nol­o­gy Stud­ies Announces Release of Trends in Neu­rotech­nol­o­gy August 2015 (Potomac Insti­tute for Pol­i­cy Stud­ies): “Rev­o­lu­tions in neu­rotech­nol­o­gy will soon influ­ence every aspect of human life. Neu­rotech­nol­o­gy can be used to fur­ther under­stand the nat­ur­al process­es of the brain, study and treat neu­ro­log­i­cal dis­or­ders and injuries, and enhance neur­al capa­bil­i­ties, result­ing in increased…

Read More

Rethinking Alzheimer’s research, beyond amyloid deposition, via new funding models

How a new approach to fund­ing Alzheimer’s research could pay off (MIT News): “More than 5 mil­lion Amer­i­cans suf­fer from Alzheimer’s dis­ease, the afflic­tion that erodes mem­o­ry and oth­er men­tal capac­i­ties, but no drugs tar­get­ing the dis­ease have been approved by the U.S. Food and Drug Admin­is­tra­tion since 2003…Lo and three co-authors propose 

Read More

Accelerating brain health research via online registries

San Fran­­cis­­co-based online ‘brain reg­istry’ seeks vol­un­teers to trans­form research (San Jose Mer­cury News): “By vol­un­teer­ing — repeat­ed­ly over time — par­tic­i­pants join a pool of research sub­jects in the new Brain Health Reg­istry, opened Tues­day, for stud­ies on brain dis­eases such as Alzheimer’s and Parkin­son’s, as well as depres­sion, post-trau­­mat­ic stress dis­or­der and oth­er neurological…

Read More